Skip to main content

Prolyl Isomerase Pin1 Regulated Signaling Pathway Revealed by Pin1 +/+ and Pin1 −/− Mouse Embryonic Fibroblast Cells

Abstract

Pin1 (peptidylprolyl cis/trans isomerase, NIMA-interacting 1) plays a key role in a number of diseases including cancer and Alzheimer disease. Previous studies have identified a wide range of phosphoproteins as Pin1 substrates. Related pathways were analyzed separately. The aim of this study was to provide a comprehensive picture involving Pin1 regulation. A genome-wide mRNA expression microarray was carried out using the RNA isolation from Pin1 +/+ and Pin1 −/− mouse embryonic fibroblast (MEF) cells. Signaling pathways regulated by Pin1 were analyzed with the utility of KEGG pathway and GO annotation. An expression pattern regulated by Pin1 was revealed. A total of 606 genes, 375 being up-regulated and 231 down-regulated, were differentially expressed when comparing Pin1 +/+ to Pin1 −/− MEF cells. Totally 48 pathways were shown to be regulated by Pin1 expression in KEGG pathway analysis. In the GO annotation system, 19 processes on biological processes, 15 processes on cellular components, and 18 processes on molecular functions were found to be in the regulation of Pin1 expression. Pathways related to immune system and cancer showed most significant association with Pin1 regulation. Pin1 is an important regulator in a wide range of signaling pathways that were related to immune system and cancer.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Lu KP, Hanes SD, Hunter T (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380(6574):544–547

    PubMed  CAS  Article  Google Scholar 

  2. Lu PJ, Zhou XZ, Shen M, Lu KP (1999) Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283(5406):1325–1328

    PubMed  CAS  Article  Google Scholar 

  3. Ranganathan R, Lu KP, Hunter T, Noel JP (1997) Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 89(6):875–886

    PubMed  CAS  Article  Google Scholar 

  4. Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld JU, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC, Lu KP (1997) Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278(5345):1957–1960

    PubMed  CAS  Article  Google Scholar 

  5. Liou YC, Ryo A, Huang HK, Lu PJ, Bronson R, Fujimori F, Uchida T, Hunter T, Lu KP (2002) Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci U S A 99(3):1335–1340

    PubMed  CAS  Article  Google Scholar 

  6. Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP (2001) Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 3(9):793–801

    PubMed  CAS  Article  Google Scholar 

  7. Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volinia S, Ronai Z, Blandino G, Schneider C, Del Sal G (2002) The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419(6909):853–857

    PubMed  CAS  Article  Google Scholar 

  8. Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G, Gu L, Tang X, Lu KP, Xiao ZX (2002) The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419(6909):849–853

    PubMed  CAS  Article  Google Scholar 

  9. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V, Lu KP (2001) Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 20(13):3459–3472

    PubMed  CAS  Article  Google Scholar 

  10. Moretto-Zita M, Jin H, Shen Z, Zhao T, Briggs SP, Xu Y (2010) Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc Natl Acad Sci U S A 107(30):13312–13317

    PubMed  CAS  Article  Google Scholar 

  11. Monje P, Hernandez-Losa J, Lyons RJ, Castellone MD, Gutkind JS (2005) Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J Biol Chem 280(42):35081–35084

    PubMed  CAS  Article  Google Scholar 

  12. Pathan N, Aime-Sempe C, Kitada S, Basu A, Haldar S, Reed JC (2001) Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1. Neoplasia 3(6):550–559

    PubMed  CAS  Article  Google Scholar 

  13. Liou YC, Zhou XZ, Lu KP (2011) Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci 36(10):501–514

    PubMed  CAS  Article  Google Scholar 

  14. Lee TH, Pastorino L, Lu KP (2011) Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev Mol Med 13:e21

    PubMed  Article  Google Scholar 

  15. Finn G, Lu KP (2008) Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer. Curr Cancer Drug Targets 8(3):223–229

    PubMed  CAS  Article  Google Scholar 

  16. Fujimori F, Takahashi K, Uchida C, Uchida T (1999) Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Commun 265(3):658–663

    PubMed  CAS  Article  Google Scholar 

  17. Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W, Fang H, Kawasaki ES, Hager J, Tikhonova IR, Walker SJ, Zhang L, Hurban P, de Longueville F, Fuscoe JC, Tong W, Shi L, Wolfinger RD (2006) Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol 24(9):1140–1150

    PubMed  CAS  Article  Google Scholar 

  18. Guo Y, Guo H, Zhang L, Xie H, Zhao X, Wang F, Li Z, Wang Y, Ma S, Tao J, Wang W, Zhou Y, Yang W, Cheng J (2005) Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol 79(22):14392–14403

    PubMed  CAS  Article  Google Scholar 

  19. Ang LS, Boivin WA, Williams SJ, Zhao H, Abraham T, Carmine-Simmen K, McManus BM, Bleackley RC, Granville DJ (2011) Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm. Cell Death Dis 2:e209

    PubMed  CAS  Article  Google Scholar 

  20. Rodvold JJ, Mahadevan NR, Zanetti M (2012) Lipocalin 2 in cancer: when good immunity goes bad. Cancer Lett 316(2):132–138

    PubMed  CAS  Article  Google Scholar 

  21. Mulero JJ, Pace AM, Nelken ST, Loeb DB, Correa TR, Drmanac R, Ford JE (1999) IL1HY1: a novel interleukin-1 receptor antagonist gene. Biochem Biophys Res Commun 263(3):702–706

    PubMed  CAS  Article  Google Scholar 

  22. Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J (2007) Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 26(44):6456–6468

    PubMed  CAS  Article  Google Scholar 

  23. Takasu S, Mutoh M, Takahashi M, Nakagama H (2012) Lipoprotein lipase as a candidate target for cancer prevention/therapy. Biochem Res Int 2012:398697

    PubMed  Google Scholar 

  24. Bolcun-Filas E, Costa Y, Speed R, Taggart M, Benavente R, De Rooij DG, Cooke HJ (2007) SYCE2 is required for synaptonemal complex assembly, double strand break repair, and homologous recombination. J Cell Biol 176(6):741–747

    PubMed  CAS  Article  Google Scholar 

  25. Esnault S, Shen ZJ, Malter JS (2008) Pinning down signaling in the immune system: the role of the peptidyl-prolyl isomerase Pin1 in immune cell function. Crit Rev Immunol 28(1):45–60

    PubMed  CAS  Article  Google Scholar 

  26. Esnault S, Braun RK, Shen ZJ, Xiang Z, Heninger E, Love RB, Sandor M, Malter JS (2007) Pin1 modulates the type 1 immune response. PLoS One 2(2):e226

    PubMed  Article  Google Scholar 

  27. Tun-Kyi A, Finn G, Greenwood A, Nowak M, Lee TH, Asara JM, Tsokos GC, Fitzgerald K, Israel E, Li X, Exley M, Nicholson LK, Lu KP (2011) Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nat Immunol 12(8):733–741

    PubMed  CAS  Article  Google Scholar 

  28. Bane FT, Bannon JH, Pennington SR, Campiani G, Williams DC, Zisterer DM, Mc Gee MM (2009) The microtubule-targeting agents, PBOX-6 [pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and pin1, in malignant hematopoietic cells. J Pharmacol Exp Ther 329(1):38–47

    PubMed  CAS  Article  Google Scholar 

  29. Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L (2003) The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 63(19):6244–6251

    PubMed  CAS  Google Scholar 

  30. Yuan WC, Lee YR, Huang SF, Lin YM, Chen TY, Chung HC, Tsai CH, Chen HY, Chiang CT, Lai CK, Lu LT, Chen CH, Gu DL, Pu YS, Jou YS, Lu KP, Hsiao PW, Shih HM, Chen RH (2011) A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression. Cancer Cell 20(2):214–228

    PubMed  CAS  Article  Google Scholar 

  31. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang DG (2004) Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 164(5):1727–1737

    PubMed  CAS  Article  Google Scholar 

  32. Kuramochi J, Arai T, Ikeda S, Kumagai J, Uetake H, Sugihara K (2006) High Pin1 expression is associated with tumor progression in colorectal cancer. J Surg Oncol 94(2):155–160

    PubMed  CAS  Article  Google Scholar 

  33. Kim CJ, Cho YG, Park YG, Nam SW, Kim SY, Lee SH, Yoo NJ, Lee JY, Park WS (2005) Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression. World J Gastroenterol 11(32):5006–5009

    PubMed  CAS  Google Scholar 

  34. Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, Benveniste EN (2009) The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 28(42):3735–3745

    PubMed  CAS  Article  Google Scholar 

  35. He J, Zhou F, Shao K, Hang J, Wang H, Rayburn E, Xiao ZX, Lee SW, Xue Q, Feng XL, Shi SS, Zhang CY, Zhang S (2007) Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer 56(1):51–58

    PubMed  Article  Google Scholar 

  36. Tan X, Zhou F, Wan J, Hang J, Chen Z, Li B, Zhang C, Shao K, Jiang P, Shi S, Feng X, Lv N, Wang Z, Ling Y, Zhao X, Ding D, Sun J, Xiong M, He J (2010) Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis. Cancer Biol Ther 9(2):111–119

    PubMed  CAS  Article  Google Scholar 

  37. Saegusa M, Hashimura M, Kuwata T (2010) Pin1 acts as a modulator of cell proliferation through alteration in NF-kappaB but not beta-catenin/TCF4 signalling in a subset of endometrial carcinoma cells. J Pathol 222(4):410–420

    PubMed  CAS  Article  Google Scholar 

  38. Plotnikov A, Zehorai E, Procaccia S, Seger R (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813(9):1619–1633

    PubMed  CAS  Article  Google Scholar 

  39. Pan CQ, Liou YC, Low BC (2010) Active Mek2 as a regulatory scaffold that promotes Pin1 binding to BPGAP1 to suppress BPGAP1-induced acute Erk activation and cell migration. J Cell Sci 123(Pt 6):903–916

    PubMed  CAS  Article  Google Scholar 

  40. Nakano A, Koinuma D, Miyazawa K, Uchida T, Saitoh M, Kawabata M, Hanai J, Akiyama H, Abe M, Miyazono K, Matsumoto T, Imamura T (2009) Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins. J Biol Chem 284(10):6109–6115

    PubMed  CAS  Article  Google Scholar 

  41. Kim MR, Choi HS, Heo TH, Hwang SW, Kang KW (2008) Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells. Biochem Biophys Res Commun 369(2):547–553

    PubMed  CAS  Article  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China (No: 30672379 and No: 30973374 to Z H), Natural Science Foundation of Guangdong Province (to Z H), Science and Technology Innovation Fund of Guangdong Medical College (No: STIF201108 to Z H), Medical Science Research Foundation of Guangdong Province (No: B2011232 to G-L H), and Science Research Foundation of Guangdong Medical College (No: B2010003 to G-L H).

Author Contributions

Experiment and data analysis: Guo-Liang Huang, Jin-Hua Qiu, Bin-Bin Li, Jing-Jing Wu, Yan Lu, Xing-Yan Liu; statistics and draft writing: Guo-Liang Huang, Jin-Hua Qiu, Bin-Bin Li; conception, design and editing: Zhiwei He.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Zhiwei He.

Additional information

Guo-Liang Huang and Jin-Hua Qiu contributed equally to this study.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Huang, GL., Qiu, JH., Li, BB. et al. Prolyl Isomerase Pin1 Regulated Signaling Pathway Revealed by Pin1 +/+ and Pin1 −/− Mouse Embryonic Fibroblast Cells. Pathol. Oncol. Res. 19, 667–675 (2013). https://doi.org/10.1007/s12253-013-9629-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-013-9629-x

Keywords

  • Pin1
  • Pathway
  • Cancer
  • Immune